Mesenchymal–epithelial transition factor (MET) is a receptor tyrosine kinase oncogenic driver in some non-small cell lung cancers (NSCLC)1, as well as in sub-groups of other cancer types2–5. This evidence concerns the gene NTRK1 and non-small cell lung carcinoma.